178 related articles for article (PubMed ID: 1659490)
1. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
Schaffel R; Rodrigues MS; Assreuy J
Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
Rodrigues MS; Schaffel R; Assreuy J
Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
[TBL] [Abstract][Full Text] [Related]
3. Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines.
Camargo A; Ferreira SH
Br J Pharmacol; 1971 Jun; 42(2):305-7. PubMed ID: 5091164
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum.
Minshall RD; Nedumgottil SJ; Igić R; Erdös EG; Rabito SF
Peptides; 2000 Aug; 21(8):1257-64. PubMed ID: 11035213
[TBL] [Abstract][Full Text] [Related]
5. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro.
Calixto JB; Pizzolatti MG; Yunes RA
Br J Pharmacol; 1988 Aug; 94(4):1133-42. PubMed ID: 3207977
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
Sekiguchi N; Ishii Y; Fujikura H; Hasegawa Y; Takayanagi I
Gen Pharmacol; 1993 May; 24(3):585-90. PubMed ID: 8396059
[TBL] [Abstract][Full Text] [Related]
7. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
8. Effect of stretching on the sensitivity of the guinea pig ileum to bradykinin and on its modification by bradykinin potentiating peptides.
Shimuta SI; Sabia EB; Paiva AC; Paiva TB
Eur J Pharmacol; 1981 Apr; 70(4):551-8. PubMed ID: 7238576
[TBL] [Abstract][Full Text] [Related]
9. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
Lindsey CJ; Bendhack LM; Paiva AC
J Hypertens Suppl; 1987 Jul; 5(2):S71-6. PubMed ID: 2821209
[TBL] [Abstract][Full Text] [Related]
10. The bradykinin potentiating activity of two pentapeptides on various isolated smooth muscle preparations.
Ufkes JG; Aarsen PN; Van Der Meer C
Eur J Pharmacol; 1976 Nov; 40(1):137-44. PubMed ID: 1033071
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
Lembeck F; Griesbacher T; Eckhardt M
Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.
Fernandes PD; Guimarães JA; Assreuy J
Agents Actions; 1991 Mar; 32(3-4):182-7. PubMed ID: 1862741
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new kinin potentiating peptide obtained from human plasma proteins.
Assreuy-Filho J; Almeida AA; Guimarães JA
Braz J Med Biol Res; 1988; 21(3):453-5. PubMed ID: 3228625
[TBL] [Abstract][Full Text] [Related]
17. Competitive antagonists of bradykinin.
Vavrek RJ; Stewart JM
Peptides; 1985; 6(2):161-4. PubMed ID: 4034408
[TBL] [Abstract][Full Text] [Related]
18. Multiple mechanisms of bradykinin-induced contraction in rat and guinea pig smooth muscles in vitro.
Calixto JB
Eur J Pharmacol; 1995 Aug; 281(3):279-88. PubMed ID: 8521911
[TBL] [Abstract][Full Text] [Related]
19. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
Farmer SG; Burch RM; Dehaas CJ; Togo J; Steranka LR
J Pharmacol Exp Ther; 1989 Feb; 248(2):677-81. PubMed ID: 2537408
[TBL] [Abstract][Full Text] [Related]
20. Application of drug receptor theories to the analysis of the myotropic effects of bradykinin.
Barabe J; Park WK; Regoli D
Can J Physiol Pharmacol; 1975 Jun; 53(3):345-53. PubMed ID: 238724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
